PROCEPT BioRobotics Corp (PRCT)
93.60
-0.85
(-0.90%)
USD |
NASDAQ |
Nov 22, 16:00
95.78
+2.18
(+2.33%)
After-Hours: 20:00
PROCEPT BioRobotics Cash from Operations (Quarterly): -18.80M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -18.80M |
| June 30, 2024 | -15.74M |
| March 31, 2024 | -32.29M |
| December 31, 2023 | -24.79M |
| September 30, 2023 | -18.94M |
| June 30, 2023 | -28.34M |
| March 31, 2023 | -35.93M |
| December 31, 2022 | -25.17M |
| Date | Value |
|---|---|
| September 30, 2022 | -19.85M |
| June 30, 2022 | -17.13M |
| March 31, 2022 | -18.23M |
| December 31, 2021 | -16.48M |
| September 30, 2021 | -12.75M |
| June 30, 2021 | -12.91M |
| March 31, 2021 | -15.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-35.93M
Minimum
Mar 2023
-12.75M
Maximum
Sep 2021
-20.84M
Average
-18.80M
Median
Sep 2024
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Intuitive Surgical Inc | 706.50M |
| Teleflex Inc | 230.98M |
| RxSight Inc | 0.65M |
| Perspective Therapeutics Inc | 3.366M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.246M |
| Cash from Financing (Quarterly) | 1.715M |
| Free Cash Flow | -103.56M |
| Free Cash Flow Per Share (Quarterly) | -0.3662 |
| Free Cash Flow to Equity (Quarterly) | -19.08M |
| Free Cash Flow Yield | -2.16% |